Index RUT
P/E -
EPS (ttm) -0.83
Insider Own 53.62%
Shs Outstand 82.83M
Perf Week 10.88%
Market Cap 442.78M
Forward P/E -
EPS next Y -0.47
Insider Trans 0.00%
Shs Float 38.75M
Perf Month -10.92%
Income -68.77M
PEG -
EPS next Q -0.16
Inst Own 47.01%
Short Float 17.62%
Perf Quarter -32.31%
Sales 235.44M
P/S 1.88
EPS this Y -13.79%
Inst Trans 11.83%
Short Ratio 12.66
Perf Half Y -45.75%
Book/sh 1.76
P/B 3.01
EPS next Y 28.79%
ROA -22.50%
Short Interest 6.83M
Perf Year -38.59%
Cash/sh 0.56
P/C 9.47
EPS next 5Y 29.80%
ROE -39.76%
52W Range 4.65 - 14.79
Perf YTD -57.36%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -26.78%
52W High -64.16%
Beta 0.97
Dividend TTM -
Quick Ratio 1.70
Sales past 5Y 19.90%
Gross Margin 65.47%
52W Low 13.98%
ATR (14) 0.39
Dividend Ex-Date -
Current Ratio 3.57
EPS Y/Y TTM 4.54%
Oper. Margin -23.13%
RSI (14) 42.46
Volatility 8.28% 7.11%
Employees 574
Debt/Eq 0.75
Sales Y/Y TTM 17.39%
Profit Margin -29.21%
Recom 1.00
Target Price 14.40
Option/Short Yes / Yes
LT Debt/Eq 0.75
EPS Q/Q -25.32%
Payout -
Rel Volume 1.32
Prev Close 5.21
Sales Surprise 1.56%
EPS Surprise -0.83%
Sales Q/Q 19.62%
Earnings Nov 12 AMC
Avg Volume 539.38K
Price 5.30
SMA20 -1.50%
SMA50 -18.58%
SMA200 -39.14%
Trades
Volume 710,152
Change 1.73%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-29-23 Initiated
William Blair
Outperform
Apr-11-23 Initiated
Stephens
Overweight
$23
Dec-14-22 Resumed
B. Riley Securities
Buy
$32
Oct-30-24 07:14AM
Oct-17-24 04:42PM
04:05PM
Oct-16-24 04:05PM
11:20AM
06:00PM
Loading…
Oct-09-24 06:00PM
10:00AM
Oct-02-24 08:00AM
Sep-30-24 02:34PM
Sep-25-24 09:00PM
02:17PM
Sep-17-24 08:38AM
Sep-16-24 09:00PM
Sep-11-24 06:32AM
Sep-10-24 09:00AM
05:37PM
Loading…
Sep-09-24 05:37PM
Sep-05-24 06:32AM
(Medical Device Network) -12.22%
Sep-04-24 09:15AM
Sep-03-24 09:00PM
12:53PM
Aug-28-24 11:58AM
Aug-26-24 09:00PM
04:13PM
Aug-22-24 02:27PM
Aug-20-24 07:31AM
Aug-19-24 04:41PM
Aug-14-24 05:36PM
(GlobeNewswire) -5.53%
+7.56%
07:00AM
Aug-13-24 02:49PM
Aug-12-24 09:00PM
11:13AM
Loading…
Aug-11-24 11:13AM
Aug-08-24 09:58PM
(InvestorPlace) +5.19%
-20.10%
04:10PM
12:17PM
10:00AM
Aug-05-24 03:26PM
Aug-02-24 03:56PM
Aug-01-24 07:13PM
Jul-17-24 04:05PM
May-13-24 10:30AM
May-10-24 02:36PM
May-09-24 10:16AM
07:46AM
(Thomson Reuters StreetEvents)
May-08-24 10:55PM
04:05PM
May-02-24 04:05PM
Apr-04-24 11:43AM
08:01AM
Apr-01-24 10:32AM
Mar-28-24 04:05PM
04:58AM
Mar-02-24 08:54AM
Mar-01-24 06:44AM
(Thomson Reuters StreetEvents) -5.77%
Feb-29-24 04:35PM
04:05PM
Feb-12-24 11:36AM
Feb-06-24 04:05PM
Feb-01-24 08:00AM
Jan-30-24 04:43PM
Jan-26-24 08:00AM
Jan-17-24 08:00AM
Jan-08-24 09:00AM
Jan-05-24 08:00AM
Dec-19-23 04:05PM
Nov-20-23 10:34AM
Nov-16-23 11:31AM
Nov-14-23 04:05PM
08:00AM
Nov-13-23 04:05PM
Nov-12-23 08:55AM
Nov-08-23 08:45AM
(Thomson Reuters StreetEvents) -7.15%
Nov-07-23 04:05PM
04:05PM
Nov-06-23 06:42AM
Nov-03-23 08:00AM
Oct-17-23 04:05PM
Sep-11-23 07:00AM
Aug-28-23 04:05PM
Aug-02-23 05:25PM
04:05PM
Jul-28-23 08:00AM
Jul-27-23 08:35AM
Jul-12-23 04:05PM
Jun-12-23 06:34AM
May-23-23 08:00AM
May-05-23 08:42AM
(Thomson Reuters StreetEvents)
May-04-23 06:55PM
04:05PM
Apr-26-23 04:05PM
Apr-24-23 04:05PM
Apr-20-23 04:05PM
Apr-18-23 05:35PM
Apr-11-23 11:49AM
Mar-03-23 08:12AM
(Thomson Reuters StreetEvents)
Mar-02-23 05:35PM
04:05PM
Mar-01-23 04:05PM
Feb-28-23 05:45PM
Feb-23-23 10:00AM
Feb-17-23 02:00PM
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. Its products include bone graft harvest system, bone marrow aspirate kits, and soft tissue fixation system. The company was founded by Albert DaCosta, Frank Bono, Jim Riegler and Lee Rosenthal in 2010 and is headquartered in Englewood, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DaCosta Albert See Remarks Mar 15 '24 Buy 9.12 28,000 255,226 5,339,110 Mar 18 05:34 PM DaCosta Albert see remarks Nov 10 '23 Buy 8.51 30,500 259,555 5,311,110 Nov 13 08:00 AM
Index RUT
P/E -
EPS (ttm) -1.23
Insider Own 55.32%
Shs Outstand 49.12M
Perf Week -1.92%
Market Cap 139.34M
Forward P/E -
EPS next Y -0.55
Insider Trans -0.05%
Shs Float 22.11M
Perf Month 5.04%
Income -60.35M
PEG -
EPS next Q -0.32
Inst Own 24.17%
Short Float 9.14%
Perf Quarter 26.80%
Sales 93.22M
P/S 1.49
EPS this Y 29.22%
Inst Trans -23.02%
Short Ratio 13.58
Perf Half Y -29.45%
Book/sh 0.45
P/B 6.26
EPS next Y 46.03%
ROA -36.29%
Short Interest 2.02M
Perf Year -19.57%
Cash/sh 0.91
P/C 3.08
EPS next 5Y -
ROE -128.20%
52W Range 1.88 - 6.31
Perf YTD -42.32%
Dividend Est. -
P/FCF -
EPS past 5Y -37.60%
ROI -58.24%
52W High -55.39%
Beta 1.36
Dividend TTM -
Quick Ratio 1.98
Sales past 5Y 23.82%
Gross Margin 53.01%
52W Low 49.73%
ATR (14) 0.18
Dividend Ex-Date -
Current Ratio 2.73
EPS Y/Y TTM 37.72%
Oper. Margin -51.65%
RSI (14) 47.45
Volatility 6.15% 6.60%
Employees 330
Debt/Eq 3.81
Sales Y/Y TTM 9.66%
Profit Margin -64.74%
Recom 2.00
Target Price 5.00
Option/Short Yes / Yes
LT Debt/Eq 3.66
EPS Q/Q 48.02%
Payout -
Rel Volume 0.59
Prev Close 2.92
Sales Surprise -1.13%
EPS Surprise -1.35%
Sales Q/Q -1.52%
Earnings Aug 05 AMC
Avg Volume 148.73K
Price 2.82
SMA20 -5.50%
SMA50 1.10%
SMA200 -18.23%
Trades
Volume 87,396
Change -3.60%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-06-24 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Aug-06-24 Downgrade
JP Morgan
Overweight → Neutral
Aug-06-24 Downgrade
BTIG Research
Buy → Neutral
Jun-21-24 Initiated
Craig Hallum
Buy
$7.50
Dec-14-23 Initiated
Guggenheim
Neutral
Jul-05-23 Resumed
JP Morgan
Overweight
$18
Feb-02-23 Initiated
UBS
Buy
$14
Nov-03-22 Initiated
CapitalOne
Overweight
$19
Oct-06-22 Initiated
Stephens
Overweight
$16
Jun-22-22 Initiated
BTIG Research
Buy
$16
Jan-06-22 Resumed
Piper Sandler
Overweight
$23
May-11-21 Initiated
Piper Sandler
Overweight
$28
May-11-21 Initiated
Morgan Stanley
Overweight
$26
May-11-21 Initiated
JP Morgan
Overweight
$23
May-11-21 Initiated
Canaccord Genuity
Buy
$25
Show Previous Ratings
Oct-28-24 08:30AM
Oct-07-24 08:00AM
Oct-03-24 04:00PM
Aug-05-24 08:59PM
05:10PM
04:07PM
Loading…
04:07PM
(Associated Press Finance)
04:00PM
Jul-15-24 04:00PM
May-15-24 08:02AM
May-14-24 01:55PM
09:01AM
08:14AM
07:34AM
May-13-24 08:54PM
05:35PM
04:36PM
Loading…
04:36PM
(Associated Press Finance)
04:00PM
May-09-24 08:00AM
May-06-24 10:00AM
08:00AM
May-02-24 08:00AM
Apr-22-24 04:05PM
Apr-05-24 08:00AM
Mar-05-24 09:52AM
07:00AM
(Thomson Reuters StreetEvents)
Mar-04-24 08:51PM
05:31PM
05:15PM
04:21PM
(Associated Press Finance)
04:05PM
04:05PM
Loading…
Feb-08-24 04:05PM
Feb-07-24 04:13AM
Jan-18-24 08:00AM
Jan-10-24 08:00AM
Jan-08-24 01:07AM
Jan-07-24 08:00AM
08:00AM
08:00AM
Jan-05-24 08:34AM
Dec-27-23 09:55AM
Dec-20-23 08:05AM
Nov-12-23 10:51AM
Nov-09-23 10:25AM
(Thomson Reuters StreetEvents) +10.90%
Nov-08-23 05:51PM
04:05PM
(Associated Press Finance)
04:00PM
Nov-02-23 08:00AM
Nov-01-23 10:01AM
Oct-31-23 09:00AM
Oct-17-23 10:22AM
Oct-11-23 04:05PM
(GlobeNewswire) -8.21%
-6.10%
Sep-19-23 08:00AM
Aug-17-23 09:56AM
Aug-08-23 12:38PM
(Thomson Reuters StreetEvents)
Aug-07-23 06:15PM
05:02PM
(Associated Press Finance)
04:05PM
08:05AM
Aug-06-23 10:57AM
Jul-26-23 04:05PM
Jul-21-23 09:21AM
Jul-12-23 09:55AM
08:05AM
Jul-10-23 10:08AM
Jun-13-23 07:58PM
(TipRanks) +20.40%
+16.79%
12:32PM
08:29AM
06:37AM
Jun-12-23 04:05PM
Jun-08-23 12:55AM
Jun-07-23 04:08PM
May-09-23 10:43AM
(Thomson Reuters StreetEvents)
May-08-23 05:35PM
04:32PM
04:05PM
May-05-23 07:36AM
Apr-27-23 08:00AM
Apr-17-23 12:20PM
Apr-14-23 03:38PM
Apr-12-23 08:00AM
08:00AM
Apr-06-23 08:00AM
Mar-20-23 04:00PM
(GlobeNewswire) -5.47%
+8.68%
Mar-09-23 05:17AM
Mar-08-23 07:21AM
Mar-07-23 09:52AM
(Thomson Reuters StreetEvents)
Mar-06-23 05:35PM
04:05PM
Feb-28-23 08:00AM
Feb-27-23 10:00AM
Feb-10-23 06:36PM
Feb-06-23 08:05AM
Feb-01-23 08:00AM
Jan-08-23 04:00PM
Jan-06-23 08:00AM
Dec-28-22 04:00PM
Dec-15-22 04:00PM
Dec-07-22 05:15AM
Nov-07-22 05:25PM
04:05PM
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
McKelligon Brian President and CEO Jun 11 '24 Option Exercise 0.30 7,500 2,272 232,233 Jun 12 04:01 PM McKelligon Brian President and CEO Jun 11 '24 Sale 2.08 7,500 15,630 224,733 Jun 12 04:01 PM McKelligon Brian President and CEO Jun 06 '24 Option Exercise 0.30 7,500 2,272 232,233 Jun 07 09:56 PM McKelligon Brian President and CEO Jun 06 '24 Sale 2.01 7,500 15,064 224,733 Jun 07 09:56 PM McKelligon Brian President and CEO Mar 20 '24 Option Exercise 0.30 7,500 2,272 239,368 Mar 22 05:54 PM McKelligon Brian President and CEO Mar 20 '24 Sale 4.97 7,500 37,243 231,868 Mar 22 05:54 PM McKelligon Brian President and CEO Mar 13 '24 Sale 4.94 7,500 37,035 224,368 Mar 14 08:41 PM McKelligon Brian President and CEO Dec 19 '23 Option Exercise 0.30 7,500 2,272 160,063 Dec 20 07:16 PM McKelligon Brian President and CEO Dec 19 '23 Sale 4.48 7,500 33,566 152,563 Dec 20 07:16 PM McKelligon Brian President and CEO Dec 12 '23 Option Exercise 0.30 7,500 2,272 160,063 Dec 14 04:24 PM McKelligon Brian President and CEO Dec 12 '23 Sale 4.25 7,500 31,871 152,563 Dec 14 04:24 PM McKelligon Brian President and CEO Nov 20 '23 Option Exercise 0.30 7,500 2,272 160,063 Nov 22 04:00 PM McKelligon Brian President and CEO Nov 20 '23 Sale 4.39 7,500 32,901 152,563 Nov 22 04:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite